Financing Options for Medical Weight Loss: A Complete Consumer Guide to Payment Structures, Costs, and Coverage

Financing options for medical weight loss have expanded significantly as patient demand for physician-supervised programs and GLP-1 medications has grown. A physician-supervised medical weight loss program in 2026 generally costs between $600 and $1,800 per month in total, depending on medication, geographic market, and program structure. 1 Because insurance coverage remains inconsistent and out-of-pocket costs can accumulate quickly, understanding the full landscape of payment pathways is essential before beginning any treatment program.

Understanding the True Cost Baseline

Before evaluating any financing product, patients benefit from understanding what a comprehensive program actually includes. Initial consultations and intake evaluations are typically one-time costs ranging from $300 to $750, and a baseline lab panel can add $150 to $600. 1 Recurring expenses for follow-up appointments, coaching, and supplemental monitoring may add $200 to $500 monthly beyond medication costs, according to a 2022 study in the Journal of Clinical Endocrinology and Metabolism. 2

Medication itself is the largest single variable. At full retail, a monthly supply of Ozempic (semaglutide) runs approximately $930 to $1,030, while tirzepatide products such as Mounjaro and Zepbound typically cost $1,000 to $1,200 per month without assistance. 3 Manufacturer self-pay programs can reduce those figures substantially; Novo Nordisk, for example, has offered Ozempic at $199 per month for starting doses and $349 for maintenance doses through its NovoCare program. 3 For endoscopic or bariatric surgical procedures, out-of-pocket costs can reach $15,000 to $30,000 when insurance is absent. 4

Healthcare Credit Cards: CareCredit and Comparable Products

Healthcare-specific credit cards are the most widely used financing tool for elective and out-of-pocket medical expenses. CareCredit, issued by Synchrony, is accepted at thousands of provider locations and offers promotional financing periods ranging from 6 to 60 months, with deferred-interest or reduced-APR structures on qualifying purchases. 5 Adia Nutrition recently announced a CareCredit partnership that allows patients to finance up to $25,000 in treatment costs, illustrating the scale that healthcare credit products can reach. 6

Patients should understand a critical distinction in healthcare credit card terms: deferred-interest promotions are not the same as zero-interest loans. If the full balance is not paid before the promotional period ends, the lender retroactively charges interest on the original purchase amount from the date of the transaction. Wells Fargo Health Advantage operates similarly and is sometimes available to patients with credit scores in the high 500s, though approval thresholds and terms vary by applicant profile. 4

Installment Financing Platforms: Cherry, PatientFi, and Affirm

Installment lending platforms have become a common alternative to traditional healthcare credit cards. Cherry Technologies is integrated at a large number of weight loss clinics, including chains operating in Arizona, California, Missouri, New York, and beyond. Typical Cherry plans run from 3 to 24 months, with true 0% APR options available for qualifying applicants and interest-bearing plans with APRs starting as low as 5.99% for others. 7 Approval decisions are generally issued within 60 seconds using a soft credit inquiry that does not affect an applicant's credit score. Missouri Medical Clinic publicly documents an example showing a $750 treatment financing at approximately $33.87 per month over 24 months. 7

PatientFi, which targets elective and aesthetic procedures including post-weight-loss body contouring, reports approving 80% of applicants including subprime credit profiles, with 100% of approvals receiving a zero-interest offer as of February 2026. 8 Approvals reach up to $60,000. For GLP-1 telehealth programs specifically, nine providers including TrimRx, Yucca Health, and CoraDoc have publicly verified Affirm acceptance, with compounded semaglutide programs starting as low as $99 per month on longer multi-month commitments. 9 Patients should note that a $99-per-month figure may represent a six-month financed package totaling approximately $595 or more, not a standalone monthly cost. 9

HSA and FSA Accounts: Pre-Tax Payment Pathways

Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs) allow patients to pay for qualifying medical weight loss expenses using pre-tax dollars, producing an effective discount of 20 to 35% depending on the individual's tax bracket. 10 Eligible expenses include physician-supervised program fees, prescription medications such as semaglutide, and diagnostic lab work. For 2025, HSA contribution limits are $4,300 for individuals and $8,550 for families, and HSA balances roll over indefinitely. FSA limits are $3,300 per person, but most FSA funds expire, with a typical grace period of 2.5 months after the plan year or a carryover cap of $660, depending on the employer's plan design. 10

Multiple clinic networks, including those operating telehealth programs, explicitly accept HSA and FSA cards directly at the point of payment. Options Medical Weight Loss, for example, lists programs starting at $199 per month for compounded semaglutide injections and designates the entire program as HSA and FSA eligible with no insurance required. 11 Patients relying on FSA funds should confirm eligibility with their plan administrator, as not all FSA plans treat all weight loss expenses identically, and itemized documentation from the provider may be required for reimbursement.

Insurance Coverage: Commercial, Medicare, and Medicaid Pathways

Commercial insurance coverage for GLP-1 weight loss medications has grown but remains uneven. According to the Kaiser Family Foundation, 68% of commercial insurers cover GLP-1 receptor agonists, though coverage rules differ substantially by policy. 2 Prior authorization typically requires documented BMI of 30 or higher (or 27 with a qualifying comorbidity such as type 2 diabetes or sleep apnea), plus evidence of at least one prior weight management attempt lasting three to six months. 12 Cigna, for instance, requires comprehensive provider-submitted records including weight history, comorbid conditions, and behavioral interventions before approving tirzepatide coverage. 12

Medicaid coverage is markedly more restricted. As of March 2026, only 13 state Medicaid programs cover GLP-1 medications for obesity treatment: Delaware, Kansas, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Rhode Island, Tennessee, Utah, Virginia, and Wisconsin. 13 California, New Hampshire, Pennsylvania, and South Carolina recently ended obesity drug coverage citing high medication costs. Medicare Part D covers certain weight loss medications including Saxenda and Wegovy for eligible beneficiaries, though individual plan cost-sharing requirements vary. 5

Personal Loans, Alternative Credit, and Bariatric-Specific Lenders

For patients whose credit profiles limit access to specialty healthcare products, personal loans and bariatric-focused lending marketplaces provide another pathway. Lenders such as Prosper Healthcare Lending and United Medical Credit specialize in medical procedure financing. ALO Bariatrics documents one marketplace partner, eFinancing Solutions, offering loan terms from 12 to 84 months with interest rates starting at 6.99% APR, no down payment, and funding within two to seven days following approval. 14 Patients with credit scores below 620 should anticipate smaller loan approvals and higher APRs, with rates potentially ranging from 24% up to the legal cap in their state. 4

Home equity loans and HELOCs represent an additional channel for homeowners seeking larger financing amounts for bariatric surgery, while 401(k) loans are used by some patients with significant retirement balances, though both carry meaningful financial risks independent of the medical treatment. BodEvolve Bariatric Surgery Center notes that a $16,000 surgery can become a $250 to $350 monthly payment using a combination of two or three financing instruments simultaneously. 15 Patients considering any multi-instrument financing strategy should consult a financial advisor to model total repayment costs across all channels.

Key Considerations and Risk Factors

No financing product eliminates the underlying cost of treatment; it restructures when and how that cost is paid. Deferred-interest healthcare credit cards impose retroactive charges if balances are not cleared before the promotional deadline, a common source of unexpected debt. Long-term installment loans for medications that require indefinite use mean ongoing treatment costs stack on top of existing loan payments. Telehealth programs advertising low per-month rates may require multi-month commitments that substantially increase the financed total. 9

Regulatory risk is also a factor specifically for compounded GLP-1 medications, which have faced FDA scrutiny. Patients financing multi-month commitments for compounded semaglutide or tirzepatide should review cancellation and refund terms carefully before signing any loan or installment agreement. Insurance coverage policies for anti-obesity medications are actively shifting, with multiple states weighing new restrictions in 2026 and 2027. 13 Any financing plan built around anticipated insurance reimbursement should account for the possibility that coverage terms may change during the repayment period.

Sources

1. Haute Living / Haute MD: How Much Does Medical Weight Loss Cost in 2026? (hauteliving.com)
2. Archynewsy: Medical Weight Loss Programs vs. Zepbound Vials: Total Cost Comparison (archynewsy.com)
3. MeetAugust.ai: Tirzepatide vs Ozempic: Which Costs Less in 2026? (meetaugust.ai)
4. Firstcard: Weight Loss Surgery Financing With Bad Credit: Options That Actually Work (firstcard.app)
5. CareCredit / Synchrony: Healthcare Financing Overview (carecredit.com)
6. StockTitan / Adia Nutrition: Adia Nutrition Partners with CareCredit to Offer up to $25,000 in Financing (stocktitan.net)
7. Missouri Medical Clinic: Financing and Monthly Payment Plans (missourimedicalclinic.com)
8. PatientFi Blog: How to Pay for Body Contouring and Liposuction with Monthly Payment Plans (blog.patientfi.com)
9. WeightLossProviderGuide: GLP-1 Providers That Accept Affirm (2026): 9 Verified Options (weightlossproviderguide.com)
10. WeightAndBody.com: Use HSA or FSA for Medical Weight Loss: WBS Guide (weightandbody.com)
11. Options Medical Weight Loss: Telehealth Medical Weight Loss with GLP-1 (optionsmedicalweightloss.com)
12. Doctronic: Does Cigna Cover Zepbound? Insurance Coverage Guide for 2026 (doctronic.ai)
13. Propel: Does Medicaid Cover Ozempic? (propel.app)
14. ALO Bariatrics: Bariatric Surgery Financing -- USA and Canada (alobariatrics.com)
15. BodEvolve Bariatric Surgery Center: Bariatric Surgery Financing: Options, Bad Credit and How to Qualify (bodevolvebariatric.com)